Skip Nav Destination
Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma
Clin Cancer Res (2022) 28 (15): 3225–3234.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Elise F. Nassif
- Emily Z. Keung
- Prapassorn Thirasastr
- Neeta Somaiah
Current Treatment Options in Oncology (2023) 24 (4): 274.
- Chang Gon Kim
- Min Hwan Kim
- Jee Hung Kim
- Seul-Gi Kim
- Gun Min Kim
- Tae Yeong Kim
- Won-Ji Ryu
- Jee Ye Kim
- Hyung Seok Park
- Seho Park
- Young Up Cho
- Byeong Woo Park
- Seung Il Kim
- Joon Jeong
- Joohyuk Sohn
Breast Cancer Research (2023) 25 (1)
- Tarek Assi
- Carine Ngo
- Matthieu Faron
- Benjamin Verret
- Antonin Lévy
- Charles Honoré
- Clémence Hénon
- Cécile Le Péchoux
- Rastilav Bahleda
- Axel Le Cesne
Current Treatment Options in Oncology (2023)
- Ashley Hickman
- Brittany L. Siontis
Current Treatment Options in Oncology (2023) 24 (4): 327.
- María López-Álvarez
- Cristina González-Aguilera
- David S. Moura
- Paloma Sánchez-Bustos
- José L. Mondaza-Hernández
- Marta Martín-Ruiz
- Marta Renshaw
- Rafael Ramos
- Carolina Castilla
- Elena Blanco-Alcaina
- Nadia Hindi
- Javier Martín-Broto
International Journal of Molecular Sciences (2022) 24 (1): 680.
RSS Feeds